207 related articles for article (PubMed ID: 35905995)
1. Dimerization of kringle 1 domain from hepatocyte growth factor/scatter factor provides a potent MET receptor agonist.
de Nola G; Leclercq B; Mougel A; Taront S; Simonneau C; Forneris F; Adriaenssens E; Drobecq H; Iamele L; Dubuquoy L; Melnyk O; Gherardi E; de Jonge H; Vicogne J
Life Sci Alliance; 2022 Jul; 5(12):. PubMed ID: 35905995
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of hepatocyte growth factor/scatter factor and MET signalling.
Gherardi E; Sandin S; Petoukhov MV; Finch J; Youles ME; Ofverstedt LG; Miguel RN; Blundell TL; Vande Woude GF; Skoglund U; Svergun DI
Proc Natl Acad Sci U S A; 2006 Mar; 103(11):4046-51. PubMed ID: 16537482
[TBL] [Abstract][Full Text] [Related]
3. Insights into the structure/function of hepatocyte growth factor/scatter factor from studies with individual domains.
Holmes O; Pillozzi S; Deakin JA; Carafoli F; Kemp L; Butler PJ; Lyon M; Gherardi E
J Mol Biol; 2007 Mar; 367(2):395-408. PubMed ID: 17258232
[TBL] [Abstract][Full Text] [Related]
4. Domain structure of hepatocyte growth factor/scatter factor (HGF/SF).
Gherardi E; Hartmann G; Hepple J; Chirgadze D; Srinivasan N; Blundell T
Ciba Found Symp; 1997; 212():84-93; discussion 93-104. PubMed ID: 9524765
[TBL] [Abstract][Full Text] [Related]
5. Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo.
Hartmann G; Prospero T; Brinkmann V; Ozcelik C; Winter G; Hepple J; Batley S; Bladt F; Sachs M; Birchmeier C; Birchmeier W; Gherardi E
Curr Biol; 1998 Jan; 8(3):125-34. PubMed ID: 9443912
[TBL] [Abstract][Full Text] [Related]
6. Molecular characteristics of HGF-SF and its role in cell motility and invasion.
Weidner KM; Hartmann G; Naldini L; Comoglio PM; Sachs M; Fonatsch C; Rieder H; Birchmeier W
EXS; 1993; 65():311-28. PubMed ID: 8380739
[TBL] [Abstract][Full Text] [Related]
7. Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP).
Donate LE; Gherardi E; Srinivasan N; Sowdhamini R; Aparicio S; Blundell TL
Protein Sci; 1994 Dec; 3(12):2378-94. PubMed ID: 7756992
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor as mitogen, motogen and morphogen, and its roles in organ regeneration.
Nakamura T
Princess Takamatsu Symp; 1994; 24():195-213. PubMed ID: 8983076
[TBL] [Abstract][Full Text] [Related]
9. NK1, a natural splice variant of hepatocyte growth factor/scatter factor, is a partial agonist in vivo.
Jakubczak JL; LaRochelle WJ; Merlino G
Mol Cell Biol; 1998 Mar; 18(3):1275-83. PubMed ID: 9488442
[TBL] [Abstract][Full Text] [Related]
10. Insights into the structure of hepatocyte growth factor/scatter factor (HGF/SF) and implications for receptor activation.
Chirgadze DY; Hepple J; Byrd RA; Sowdhamini R; Blundell TL; Gherardi E
FEBS Lett; 1998 Jun; 430(1-2):126-9. PubMed ID: 9678607
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of hepatocyte growth factor isoforms on epithelial and endothelial tubulogenesis.
Montesano R; Soriano JV; Malinda KM; Ponce ML; Bafico A; Kleinman HK; Bottaro DP; Aaronson SA
Cell Growth Differ; 1998 May; 9(5):355-65. PubMed ID: 9607557
[TBL] [Abstract][Full Text] [Related]
12. A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis.
Hartmann G; Naldini L; Weidner KM; Sachs M; Vigna E; Comoglio PM; Birchmeier W
Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11574-8. PubMed ID: 1280830
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of MET receptor dimerization by the bacterial invasion protein InlB and the HGF/SF splice variant NK1.
Niemann HH
Biochim Biophys Acta; 2013 Oct; 1834(10):2195-204. PubMed ID: 23123275
[TBL] [Abstract][Full Text] [Related]
14. Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor.
Mizuno K; Inoue H; Hagiya M; Shimizu S; Nose T; Shimohigashi Y; Nakamura T
J Biol Chem; 1994 Jan; 269(2):1131-6. PubMed ID: 8288571
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of hepatocyte growth factor/scatter factor neutralizing antibodies: inhibition of tumor growth in both autocrine and paracrine hepatocyte growth factor/scatter factor:c-Met-driven models of leiomyosarcoma.
Gao CF; Xie Q; Zhang YW; Su Y; Zhao P; Cao B; Furge K; Sun J; Rex K; Osgood T; Coxon A; Burgess TL; Vande Woude GF
Mol Cancer Ther; 2009 Oct; 8(10):2803-10. PubMed ID: 19825800
[TBL] [Abstract][Full Text] [Related]
16. A Novel HGF/SF Receptor (MET) Agonist Transiently Delays the Disease Progression in an Amyotrophic Lateral Sclerosis Mouse Model by Promoting Neuronal Survival and Dampening the Immune Dysregulation.
Vallarola A; Tortarolo M; De Gioia R; Iamele L; de Jonge H; de Nola G; Bovio E; Pasetto L; Bonetto V; Freschi M; Bendotti C; Gherardi E
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198383
[TBL] [Abstract][Full Text] [Related]
17. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development.
Sonnenberg E; Meyer D; Weidner KM; Birchmeier C
J Cell Biol; 1993 Oct; 123(1):223-35. PubMed ID: 8408200
[TBL] [Abstract][Full Text] [Related]
18. A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist.
Tolbert WD; Daugherty J; Gao C; Xie Q; Miranti C; Gherardi E; Vande Woude G; Xu HE
Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14592-7. PubMed ID: 17804794
[TBL] [Abstract][Full Text] [Related]
19. Mode of receptor binding and activation by plasminogen-related growth factors.
Miller M; Leonard EJ
FEBS Lett; 1998 Jun; 429(1):1-3. PubMed ID: 9657372
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the NK1 fragment of human hepatocyte growth factor at 2.0 A resolution.
Ultsch M; Lokker NA; Godowski PJ; de Vos AM
Structure; 1998 Nov; 6(11):1383-93. PubMed ID: 9817840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
